Cargando…

Pulmonary non-tuberculous mycobacterial infections: current state and future management

Currently, there is a trend of increasing incidence in pulmonary non-tuberculous mycobacterial infections (PNTM) together with a decrease in tuberculosis (TB) incidence, particularly in developed countries. The prevalence of PNTM in underdeveloped and developing countries remains unclear as there is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chin, Kai Ling, Sarmiento, Maria E., Alvarez-Cabrera, Nadine, Norazmi, Mohd Nor, Acosta, Armando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222044/ https://www.ncbi.nlm.nih.gov/pubmed/31853742 http://dx.doi.org/10.1007/s10096-019-03771-0

Ejemplares similares

Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK
por: Lipman, Marc, et al.
Publicado: (2020)

Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis
por: Chin, Kai Ling, et al.
Publicado: (2017)

Immunogenicity of recombinant Mycobacterium bovis bacille Calmette–Guèrin clones expressing T and B cell epitopes of Mycobacterium tuberculosis antigens
por: Mohamud, Rohimah, et al.
Publicado: (2013)

Does our Mycobacteriome Influence COVID-19 Morbidity and Lethality?
por: Acosta, Armando, et al.
Publicado: (2021)

Second international congress on immunopharmacology: delivery systems and current strategies for drug design
por: Acevedo, Reinaldo, et al.
Publicado: (2013)

Transcriptomic Signature of Horseshoe Crab Carcinoscorpius rotundicauda Hemocytes’ Response to Lipopolysaccharides
por: Sarmiento, Maria E., et al.
Publicado: (2022)

Immunomodulatory Effects of Recombinant Mycobacterium smegmatis Expressing Antigen-85B Epitopes in Infected J774A.1 Murine Macrophages
por: Kadir, Nur-Ayuni, et al.
Publicado: (2020)

Vaccines for TB: Lessons from the Past Translating into Future Potentials
por: Tye, Gee Jun, et al.
Publicado: (2015)

Overlapping of Pulmonary Fibrosis of Postacute COVID-19 Syndrome and Tuberculosis in the Helminth Coinfection Setting in Sub-Saharan Africa
por: Fonte, Luis, et al.
Publicado: (2022)

Mitochondrial DNA sequence of the horseshoe crab Tachypleus gigas
por: Sarmiento, Maria E., et al.
Publicado: (2021)

The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease
por: Alkarni, Meyad, et al.
Publicado: (2023)

COVID-19 Lethality in Sub-Saharan Africa and Helminth Immune Modulation
por: Fonte, Luis, et al.
Publicado: (2020)

Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
por: Kumar, Kartik, et al.
Publicado: (2021)

Passive administration of purified secretory IgA from human colostrum induces protection against Mycobacterium tuberculosis in a murine model of progressive pulmonary infection
por: Alvarez, Nadine, et al.
Publicado: (2013)

Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, Mali
por: Kone, B., et al.
Publicado: (2018)

Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China
por: Hu, Chunmei, et al.
Publicado: (2019)

The lung microbiota in Korean patients with non-tuberculous mycobacterial pulmonary disease
por: Kang, Sung-Yoon, et al.
Publicado: (2021)

Factors affecting in-hospital mortality of non-tuberculous mycobacterial pulmonary disease
por: Tanaka, Goh, et al.
Publicado: (2021)

Case studies to illustrate good practice in the management of non-tuberculous mycobacterial pulmonary disease
por: Tiberi, Simon, et al.
Publicado: (2022)

Non-Tuberculous Mycobacterial Diseases in Children
por: Meoli, Aniello, et al.
Publicado: (2020)

Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease
por: Lee, Meng-Rui, et al.
Publicado: (2013)

Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study
por: Veziris, Nicolas, et al.
Publicado: (2021)

British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
por: Haworth, Charles S, et al.
Publicado: (2017)

Textbook of tuberculosis & non-tuberculous mycobacterial diseases
por: Kant, Surya
Publicado: (2021)

Protective Effect of a Lipid-Based Preparation from Mycobacterium smegmatis in a Murine Model of Progressive Pulmonary Tuberculosis
por: García, Maria de los Angeles, et al.
Publicado: (2014)

Whole Genome Sequencing in the Management of Non-Tuberculous Mycobacterial Infections
por: Dohál, Matúš, et al.
Publicado: (2021)

Monocyte-derived macrophages do not explain susceptibility to pulmonary non-tuberculous mycobacterial disease
por: de Jong, Emma, et al.
Publicado: (2012)

Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases
por: Sharma, Surendra K., et al.
Publicado: (2020)

Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease
por: Pennington, Kelly M., et al.
Publicado: (2021)

L-Tyrosine Limits Mycobacterial Survival in Tuberculous Granuloma
por: Gao, Yaxian, et al.
Publicado: (2023)

In Silico identification of M. TB proteins with diagnostic potential
por: Calero, Romel, et al.
Publicado: (2013)

Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis
por: Vande Weygaerde, Yannick, et al.
Publicado: (2019)

Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005–2011
por: Ringshausen, Felix C, et al.
Publicado: (2013)

Non-tuberculous mycobacterial ocular infection masquerading as choroidal tumour – a diagnostic conundrum
por: Yeap, Khy Ching, et al.
Publicado: (2019)

Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
por: Ruth, Mike Marvin, et al.
Publicado: (2020)

Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection
por: Shaw, Timothy David, et al.
Publicado: (2021)

Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease
por: Ratnatunga, Champa N., et al.
Publicado: (2022)

Non-tuberculous mycobacterial disease associated with Mycobacterium montefiorense in salamanders
por: Komine, Takeshi, et al.
Publicado: (2023)

Application of diagnostic criteria for non-tuberculous mycobacterial disease to a case series of mycobacterial-positive isolates
por: Ghio, Andrew J., et al.
Publicado: (2019)

In silico identification of common epitopes from pathogenic mycobacteria
por: de la Caridad Addine Ramírez, Bárbara, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3nmu0eoearqj93jk191hu0qfuj